ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models

Despite the availability of molecularly targeted treatments such as antibodies and small molecules for human epidermal growth factor receptor 2 (HER2), hormone receptor (HR), and programmed death-ligand 1 (PD-L1), limited treatment options are available for advanced metastatic breast cancer (MBC), w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Linxi, Mu, Qingxin, Yu, Jesse, Griffin, James I., Xu, Xiaolin, Ho, Rodney J. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779833/
https://www.ncbi.nlm.nih.gov/pubmed/35056985
http://dx.doi.org/10.3390/pharmaceutics14010089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779833/
https://www.ncbi.nlm.nih.gov/pubmed/35056985
http://dx.doi.org/10.3390/pharmaceutics14010089

Ejemplares similares